VCIP, ascorbyl tetraisopalmitate, is an improved form of vitamin C ester. Unlike vitamin C, VCIP is oil soluble, provides better skin penetration and absorption without need of especially low pH and its associated side effects. Increasing collagen and glycosaminoglycans production, VCIP is a strong anti-oxidant and anti-inflammatory active that enhances skin repair, lightening and moisturizing. In order to deliver stable and active VCIP to the skin, Tagra Biotechnologies Ltd. developed Tagravit™ C1, microencapsulated ascorbyl tetraisopalmitate, with its unique RND™ Technology.
Tagra™ technology has enabled 25% VCIP capsule loading while keeping all beneficial properties , significantly increasing its stability and efficacity. The degradation rate of Tagra™ microencapsulated.